<List><item><source>MED</source><extId>29523169</extId><pmcid>PMC5845183</pmcid><annotations><annotation><prefix>he Vigip-SEP study (</prefix><exact>NCT03029897</exact><postfix>), using the App My </postfix><tags><tag><name>NCT03029897</name><uri>http://identifiers.org/clinicaltrials/NCT03029897</uri></tag></tags><id>http://europepmc.org/abstract/MED/29523169#europepmc-96be6bb558974e727b64556749154de8</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>EGISTRATION:ClinicalTrials.gov , ID: </prefix><exact>NCT03029897</exact><postfix> . </postfix><tags><tag><name>NCT03029897</name><uri>http://identifiers.org/clinicaltrials/NCT03029897</uri></tag></tags><id>http://europepmc.org/abstract/MED/29523169#europepmc-e41e09f6e6903cba469739ccea617795</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>